MC Plus Material – 01_Overview of the FY2026 Medical Fee Revision: 1. Wage Increases and Price Response (Wage Increases) Page 5 – Health Policy Information Center

News Highlights

Information from the Health Policy Information Center regarding the “Overview of the FY2026 Medical Fee Revision (Wage Increases and Price Response)”. This revision primarily focuses on supporting wage increases and responding to rising prices for medical institutions. From the perspective of medical M&A and business succession, key discussion points include the importance of management and succession strategies that consider the revision cycle, economies of scale through group participation (maintaining facility standards and distributing equipment investment costs), and the utilization of tax schemes, including conversion to specific medical corporations and social medical corporations.

M&A Medical Editorial Department’s Perspective

This news, focusing on the overview of the FY2026 medical fee revision, particularly “Wage Increases and Price Response,” directly impacts the revenue of medical institutions. It should be viewed not merely as a response to the revision, but as a turning point for M&A and business succession strategies. For example, medical institutions finding it difficult to increase personnel costs or invest in equipment independently may benefit from economies of scale through group formation, enabling them to maintain facility standards or jointly acquire expensive equipment. Furthermore, changing the legal status of a medical corporation (becoming a specific medical corporation or social medical corporation) can significantly contribute to improving post-succession cash flow, especially when combined with tax preferential measures. Therefore, collaboration with tax accountants and M&A advisors from the initial stages is essential.

Discussion Points Indicated by This News

• The impact of wage increase and price response measures in the FY2026 revision on the revenue structure of medical institutions.
• Specific details of economies of scale through group formation (maintaining facility standards, distributing equipment investment costs).
• Tax benefits and their impact on succession strategies resulting from conversion to specific medical corporations and social medical corporations.
• The necessity of viewing the revision cycle as an opportune time for executing M&A and business succession strategies.

Practical Questions Arising from This News

• To what extent is our hospital expected to see an increase in personnel costs due to this medical fee revision?
• How can joint purchasing and equipment sharing be practically realized through group formation?
• What are the specific requirements for fundraising through donations and the obligations for contributing to regional healthcare when becoming a social medical corporation?

If You Feel “Should I Consult Too?”

If you feel that the impact of this medical fee revision on revenue, particularly the response to wage increases and rising prices, is pressuring your management. Also, if you have concerns about future independent equipment investment or securing personnel and wish to explore options that offer economies of scale. Furthermore, if you are seeking professional advice on more fundamental business succession and M&A strategies, including medical corporation conversions and the utilization of tax schemes, it may be time to consider consulting with an M&A intermediary.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a certified M&A support institution by the Small and Medium Enterprise Agency, with a full success fee basis. We handle consultations with strict confidentiality. Free consultation here